MONOCLONAL ANTIBODY PRODUCTION

单克隆抗体生产

• 批准号: 8172729
• 负责人: KAREN S RICE
• 金额: $ 0.21万
• 依托单位: TEXAS BIOMEDICAL RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8172729
• 关键词: Animals; Antibodies; Biological Assay; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Enzyme-Linked Immunosorbent Assay; Funding; Goals; Grant; Hemorrhage; Human; Immune Sera; Institution; Research; Research Personnel; Resources; Running; Serum; Source; Subcutaneous Injections; Techniques; Testing; United States National Institutes of Health; improved; monoclonal antibody production; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this study was to produce antisera of an antibody testing in a clinical trial. To improve the assay to determine if anti-Abs are being produced, positive control material needed to be made. The antibody has been well tolerated, with only a few anti-Ab responses to date in human, not enough serum was produced to use as a positive control for all the assays run during the clinical trials. Previously used animal was used once again because of known antibodies and received weekly subcutaneous injections. When enough antibodies were present in the serum (as determined by ELISA techniques) a single large volume bleed was collected.

这个子项目是众多研究子项目之一